Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 4Recruiting 3Terminated 2Completed 2

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Ototoxicity 1Neoplasms 1

Interventions

Cyclophosphamide 1492Cisplatin 1413Paclitaxel 1316Radiotherapy 1261Carboplatin 1249Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700Etoposide 678pembrolizumab 677Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Hydroxymethylglutaryl-CoA Reductase Inhibitors × Clear all
NCT06553157 2026-01-20

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Minia University

Phase 1/2 Completed
56 enrolled

Ototoxicity

NCT00572468 2017-07-13

Statin Therapy Versus Placebo Prior to Prostatectomy

VA Office of Research and Development

Phase NA Completed
42 enrolled 9 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡